Mycobacterium tuberculosis Rv0679c protein sequences involved in host-cell infection: potential TB vaccine candidate

Diana P Cifuentes1, Marisol Ocampo, Hernando Curtidor

  • 1Fundación Instituto de Inmunología de Colombia, Carrera 50 No, 26-20, Bogotá, Colombia.

BMC Microbiology
|April 15, 2010
PubMed
Abstract

Insights

Researchers explored peptides from Mycobacterium tuberculosis Rv0679c protein to understand their role in host cell invasion. Specific peptides effectively inhibited bacterial entry, suggesting potential therapeutic targets for tuberculosis control.

Area of Science:

  • Microbiology
  • Immunology
  • Protein Science

Background:

  • Many Mycobacterium tuberculosis membrane proteins, including Rv0679c, have unknown functions and roles in host interactions.
  • Understanding these proteins is crucial for developing new tuberculosis control strategies.

Purpose of the Study:

  • To investigate the biological activity of peptides derived from the hypothetical membrane protein Rv0679c.
  • To assess the involvement of Rv0679c in pathogen-host interactions and mycobacterial invasion.

Main Methods:

  • Studied Rv0679c gene transcription across 26 Mycobacterium spp. strains.
  • Utilized Western blot and immunoelectron microscopy with anti-Rv0679c antibodies.
  • Tested synthetic peptides for cell binding and inhibition of M. tuberculosis invasion.

Main Results:

  • Rv0679c gene was detected in all M. tuberculosis complex strains, with transcription observed in specific strains (M. tuberculosis H37Rv, H37Ra, M. africanum).
  • Anti-Rv0679c antibodies confirmed protein localization on the mycobacterial surface.
  • Four high-activity binding peptides (HABPs) inhibited M. tuberculosis invasion into host cells by up to 75%.

Conclusions:

  • Rv0679c HABPs, particularly HABP 30979, play a significant role in M. tuberculosis host cell invasion.
  • These HABPs represent promising research targets for developing novel tuberculosis control strategies.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...